PT2385: Clinical Trials

1 trial of PT2385, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow PT2385: new trials by email Literature Review of PT2385 trials Research Report on PT2385

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers
PT2385 - Healthy
Phase 1CompletedPeloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)162015-09-012015-12-10

Sponsors

Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)

Countries

United States (1)